Centre Leon Berard

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

108

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

3 drugs in development

Phase 31

Phase 21

Preclinical2

By Therapeutic Area

top 1

Oncology

3100%

R&D Momentum

64/100

Pipeline Velocity

25/100

Trial Completion Rate

74/100

Pipeline Concentration

100/100

Pipeline Freshness

51/100

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Recruiting

ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer

Oct 23, 2026

Active, not recruiting

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments

Earlier

Oct 22, 2026TrialRepositioning and Immobilisation Assessment for Head and Neck Treatment Localisation in Sitting Position

Oct 21, 2026TrialPreoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

Oct 21, 2026TrialBiomarker Investigation for Early Gastric Cancer Detection: a Prospective Study in Gastric and Gastroesophageal Junction Adenocarcinomas (G/GEJ)

Oct 1, 2026TrialA Multicentre, Single Arm, Phase 1/2 Study, Aiming to Assess the Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients

Sep 26, 2026TrialA Multicenter, Open-label, Proof of Concept Phase II Aiming to Assess the Clinical and Biological Activity of Anti-netrin-1 (NP137) as Add on Therapy in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Immunotherapies

Sep 19, 2026TrialPRadR2 - A Single Center, Open-label, Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma

4 more events

Sep 16, 2026TrialProspective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas

Sep 16, 2026TrialEvaluation of the Contribution of Multicenter Expertise (Radiotherapists and Physicists) and Use of Deformable Fusion Software Allowing the Accumulation of Doses in Equivalent Dose 2 Grays for Re-irradiations With Curative Intent

Sep 15, 2026TrialA Multicenter, Open-label Phase I/II Trial Aiming to Assess the Safety and Clinical Activity of Tarlatamab in Combination With Metronomic Temozolomide in Adolescents and Adults' Patients With High Grade Brain Tumors

Sep 11, 2026TrialImmunotherapy in MSI/dMMR Tumors in Perioperative Setting.